The Global Allergy Immunotherapy Market Growth Accelerated By Rising Prevalence Of Allergies

Pooja Khodke

The Global Allergy Immunotherapy Market Growth Accelerated By Rising Prevalence Of Allergies

Allergy immunotherapy, also known as desensitization or hypo-sensitization, involves gradual exposure to increasing doses of an allergen to build tolerance and reduce hypersensitivity, symptoms and medication dependence in allergic people. It is administered under medical guidance and is effective for various types of allergies including allergic rhinitis and asthma.

The global Allergy Immunotherapy Market is estimated to be valued at Us$ 2312.79 Mn in 2024 and is expected to exhibit a CAGR Of 5.9% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Sublingual immunotherapy (SLIT) is gaining popularity due to its ease of use, safety and cost-effectiveness over other conventional allergen immunotherapy techniques like injections. People can self-administer SLIT at home by placing allergen extracts under the tongue with decreasing dependence on frequent doctor visits. The high profit margins associated with SLIT compared to injections is prompting industry players like B. Braun Vet Care GmbH, Biomay AG, Vivalis (InvivoGen) and others to focus on the development and commercialization of novel SLIT therapies. The growing preference for SLIT over conventional injections is expected to boost the allergy immunotherapy market during the forecast period.

Segment Analysis

Allergy immunotherapy is administered to patients through subcutaneous or sublingual routes. The subcutaneous immunotherapy (SCIT) segment currently dominates the global allergy immunotherapy market. SCIT provides long-lasting relief from allergies. It involves slowly exposing patients to increasing doses of allergens to build tolerance. However, the sublingual immunotherapy (SLIT) segment is growing at a fast pace. SLIT involves administering doses of allergen extracts under the tongue, offering a convenient mode of administration without using injections.

Key Takeaways

The Global Allergy Immunotherapy Market Demand is expected to witness high growth over the forecast period driven by the rising burden of allergic diseases globally. The global Allergy Immunotherapy Market is estimated to be valued at US$ 2312.79 Mn in 2024 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030.

Regional analysis:

North America currently accounts for the largest share of the global allergy immunotherapy market. This is primarily attributed to the developed healthcare infrastructure and growing allergic patient population in the region. Europe is anticipated to register the highest CAGR during 2023-2030, owing to increasing product approvals and government support for allergy therapeutics in countries such as Germany, UK, and France.

Key players:

Key players operating in the allergy immunotherapy market are B. Braun Vet Care GmbH, BioMérieux SA, Biotech Company, Inmunotek SL., Stallergenes Greer, Allergy Therapeutics, ALK Abelló, HAL Allergy Group, LETIPharma, and Dechra Pharmaceuticals PLC. B.Braun Vet Care GmbH dominates the market with its wide product portfolio for both subcutaneous and sublingual immunotherapy.

Get more insights on this topic :

https://www.insightprobing.com/the-growing-global-demand-for-allergy-immunotherapy-is-driven-by-increasing-prevalence-of-allergies/

Check more trending articles on this topic:

https://allmeaninginhindi.com/unveiling-the-stealthy-threat-of-catheter-related-blood-stream-infection/

Pooja Khodke

Allergy Immunotherapy Market 2023 : Analysis By Top Key Players, Trends, Industry Size And Regional Outlook 2032 | LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics PLC., ALK-Abelló A/S, HAL Allergy B.V.

Soumyanath 2023-05-19

The Business Research Company’s Allergy Immunotherapy Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The Allergy Immunotherapy Global Market Report 2023 evaluates allergy immunotherapy market size, growth rate, drivers, trends, and major companies. id=9416&type=smp The global allergy immunotherapy market size is expected to grow from $2. The global allergy immunotherapy market size is expected to grow to $3. Get More Information On The Allergy Immunotherapy Market Report: https://www.

Allergy Immunotherapy Market Trends, Share, Market Size, Growth, Opportunities, and Market Forecast to 2027

Market Research 2022-01-07

85% CAGR between 2016-2023, reveals the latest Market Research Future (MRFR) report. Allergen immunotherapy or allergy shots, simply put, is a long-term treatment that helps in decreasing symptoms for many with stinging insect allergy, eye allergy, allergic asthma, and allergic rhinitis. com/sample_request/1517Market Segmentation The Market Research Future report provides an all-inclusive segmental analysis of the allergy immunotherapy market on the basis of treatment and allergy type. Factors pushing the growth of the allergy immunotherapy market in the region include increasing incidence of various chronic diseases such as hypertension, diabetes, allergy, and asthma, growing awareness about allergy immunotherapy treatments, and elevated occurrence of skin allergy and allergic rhinitis. com/reports/allergy-immunotherapy-market-1517 About US:Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Allergy Immunotherapy Market Is Estimated To Witness High Growth Owing To The Growing Need For New Therapies For Allergy Sufferers

Ashish Thapa 2024-02-02

The growing prevalence of allergic diseases and the need for new therapies with less potential side-effects have been driving the demand for allergy immunotherapy products. The global Allergy Immunotherapy Market is estimated to be valued at US$ 2664. Porter's Analysis Threat of new entrants: Low capital requirements and established customer base make it easy for new companies to enter the market. Key Takeaways The global Allergy Immunotherapy market is expected to witness high growth over the forecast period till 2031. The global Allergy Immunotherapy Market is estimated to be valued at US$ 2664. Key players operating in the Allergy Immunotherapy market are B.

Allergy Immunotherapy Market is Expected to be Flourished by Growing Preference for Customized Therapy

ashwinicmi 2024-01-19

Segment AnalysisThe global allergy immunotherapy market is dominated by the subcutaneous immunotherapy segment, which accounts for over 95% of the market share. PEST AnalysisPolitical: Allergy immunotherapy is regulated by various regulatory bodies globally to ensure safety and efficacy. Key TakeawaysThe global allergy immunotherapy market is expected to witness high growth over the forecast period. Regional analysis: North America is anticipated to hold a significant share in the global allergy immunotherapy market due to rising environmental pollution, genetic predisposition, and increasing healthcare expenditure. Key players: Key players operating in the allergy immunotherapy market are ALK, Stallergenes Greer, HAL Allergy Group, DBV Technologies, ASIT Biotech.

Allergy Immunotherapy Market Is Estimated To Witness High Growth Owing To Increasing Prevalence Of Allergies

Poonam 2023-11-08

The allergy immunotherapy market is estimated to be valued at US$ 2312. These advantages of immunotherapy treatment and rising allergy cases are expected to fuel the market growth over the forecast period. Key Takeaways: The global Allergy Immunotherapy Market Share Size is expected to witness high growth, exhibiting CAGR of 9. Regional analysis North America dominates the global allergy immunotherapy market growing at CAGR of 8. Key players operating in the Allergy Immunotherapy market are Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics, Allergopharma, HAL Allergy Group, Aimmune Therapeutics, DBV Technologies, Leti Pharma, and Jubilant HollisterStier.

Allergy Immunotherapy Market is Estimated To Witness High Growth Owing To Increasing Prevalence of Allergies

Pooja salve 2023-09-22

The global Allergy Immunotherapy Market is estimated to be valued at US$ 2,116. The global allergy immunotherapy market is driven by the increasing prevalence of allergies, with a growing number of individuals suffering from various types of allergic conditions such as asthma, hay fever, and food allergies. The need for effective and long-term treatment options for allergies is fueling the demand for allergy immunotherapy products. PEST Analysis Political: The political factor affecting the allergy immunotherapy market is the regulatory framework set by government authorities for the approval and commercialization of allergy immunotherapy products. In terms of regional analysis, North America is anticipated to be the fastest-growing and dominating region in the allergy immunotherapy market.

WHO TO FOLLOW